Reproductive Rights Hang in the Balance
Abortion Access Under Threat
The outcome of the recent election has left many wondering about the future of reproductive rights in the United States. Despite voters in seven out of 10 states approving ballot measures to safeguard abortion rights, the election of President-elect Donald Trump has sparked concerns about the accessibility of abortion services.
A Shifting Landscape
Trump’s stance on abortion has been inconsistent, and his appointees to federal agencies could impose restrictions on abortion without requiring Congress to pass new legislation. This could lead to a further crackdown on abortion, putting the health of many patients, especially those who are lower-income or people of color, at risk.
The Consequences of Restricting Abortion
According to experts, restricting abortion could lead to worse health outcomes, with people suffering and dying unnecessarily. Katie O’Connor, senior director of federal abortion policy at the National Women’s Law Center, warns that “as long as we have a government that is not fully committed to abortion access for everyone who seeks it, there is going to be chaos and confusion on the ground around what is legal and what is available.”
Medication Abortion Under Threat
One area of concern is the potential restriction of medication abortion, which accounts for 63% of all abortions in the U.S. Trump’s administration could use an interpretation of the Comstock Act, a law passed in 1873, to block the shipment and distribution of abortion pills and medical equipment used in abortion procedures. This could prevent doctors from performing abortions at hospitals.
Executive Power and Agency Appointments
Trump could also appoint anti-abortion leaders to key federal agencies, such as the Department of Health and Human Services, the Food and Drug Administration, and the Department of Justice. These agencies have the power to severely limit or ban abortion in the U.S. through executive actions.
The FDA’s Role
The FDA could restrict or eliminate access to mifepristone, one of two drugs used in a common medication abortion regimen. Trump’s FDA appointees could push to roll back changes made between 2016 and 2021 that expanded access to mifepristone, effectively eliminating access to the pill via telehealth.
Telehealth and Abortion Access
Restricting telehealth as an option for abortion would have a significant impact on access to care. Alina Salganicoff, senior vice president and director of Women’s Health Policy at KFF, notes that this would lead to more people traveling to access care, resulting in delays and potentially being denied care due to difficulties related to getting the procedure in person.
Reinstating Previous Policies
Trump could reinstate policies implemented during his first term that made abortions harder to obtain, such as the domestic gag rule, which prohibited providers from referring patients for abortion care or providing counseling that includes abortion information. This rule decimated the network of family planning clinics and constrained their ability to serve low-income patients.
A Uncertain Future
The future of reproductive rights in the United States remains uncertain. With Trump’s election, many are left wondering what actions he will take to restrict abortion access and how this will impact the health and well-being of women across the country.
Leave a Reply